c-Met as a Prognostic Marker in Gastric Cancer: A Systematic Review and Meta-Analysis

Gastroesophageal Cancers: Progress and Problems

(2017) Jaffer A. Ajani   Journal of the National Comprehensive Cancer Network

Adenocarcinomas on the Rise — Does it Influence Survival from Oesophageal Cancer?

(2017) M. A. Goscinski et al.   Scandinavian Journal of Surgery

MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome

(2012) H E Lee et al.   BRITISH JOURNAL OF CANCER

Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma

(2012) Yin Li et al.   JOURNAL OF SURGICAL ONCOLOGY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer

(2011) Yuji Toiyama et al.   INTERNATIONAL JOURNAL OF CANCER

Genetic Activation of theMETPathway and Prognosis of Patients With High-Risk, Radically Resected Gastric Cancer

(2011) Francesco Graziano et al.   JOURNAL OF CLINICAL ONCOLOGY

METAmplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib

(2011) Jochen K. Lennerz et al.   JOURNAL OF CLINICAL ONCOLOGY

Race and ethnicity correlate with survival in patients with gastric adenocarcinoma

(2009) J. Kim et al.   ANNALS OF ONCOLOGY

Assessment of a HER2 scoring system for gastric cancer: results from a validation study

(2008) M Hofmann et al.   HISTOPATHOLOGY